Effects of Chimonanthus nitens Oliv. Leaf Extract on Glycolipid Metabolism and Antioxidant Capacity in Diabetic Model Mice

Table 6

The LC and serum ALT, AST, and ALP levels in each group after 4 weeks of treatment.

Groups	LC (mg/g)	ALT (U/L)	AST (U/L)	ALP (U/L)
NC	46.47 ± 3.80	24.14 ± 7.22	66.29 ± 6.65	37.43 ± 9.57
DM	57.40 ± 8.21^ΔΔ	151.43 ± 27.23^ΔΔ	213.86 ± 22.36^ΔΔ	141.86 ± 35.04^ΔΔ
COE-L	54.55 ± 3.73^Δ	99.67 ± 18.11^ΔΔ	187.00 ± 53.74^ΔΔ	130.00 ± 58.61^ΔΔ
COE-H	49.86 ± 2.70	50.00 ± 19.13^Δ	136.50 ± 62.86^Δ	67.50 ± 13.85
ROS	50.68 ± 7.79	65.00 ± 17.25^ΔΔ	142.33 ± 56.45^Δ	95.50 ± 17.65^ΔΔ

Data were presented as mean ± standard deviation (). LC: liver coefficient; ALT: glutamic-pyruvic transaminase; AST: aspartate aminotransferase; ALP: alkaline phosphatase. Mice were supplemented with COE at 50 (COE-L) or 200 (COE-H) mg/kg body weight and rosiglitazone at 4 mg/kg body weight (ROS) for 4 weeks. and compared to group DM; ^Δ and ^ΔΔ compared to group NC.